AFNewsNG
Latest Breaking News In Nigeria

Health: Akwa Ibom Leads As NCDC Confirms 32 COVID-19 Delta Variant Cases In Four States

0

The Nigeria Centre for Disease Control (NCDC), has confirmed 32 cases of the COVID-19 Delta Variant in four states.

The NCDC Director-General, Dr Chikwe Ihekweazu, revealed this during a resumed briefing of the Presidential Steering Committee (PSC) on Monday, August 2, in Abuja.

According to Ihekweazu, out of Lagos, Cross River, Oyo states, including the Federal Capital Territory (FCT), Akwa Ibom state has the highest number of cases as it has recorded Nineteen.

READ ALSO  WORLD AIDS DAY: How Nigeria Can Stop The Spread Of HIV – NACA DG

The other states mentioned has recorded at least one case of the Delta variant of COVID-19, the NCDC boss said.

Speaking also at the briefing, the Minister for Health, Dr Osagie Ehanire, expressed worry over the variant which has been ravaging other countries but has now come into Nigeria. He warned the public against travelling to; Lagos, Akwa Ibom, Oyo, Cross River, Kano, Plateau states including the FCT except when necessary.

READ ALSO  NCDC Confirms 16 New Cases Of Monkeypox From 12 States

High point at the briefing, was the official handing over of more than four million doses of Moderna COVID-19 vaccines to Nigeria by the United States.

However, the National Agency for Food and Drug Administration and Control (NAFDAC) would have to certify the vaccines for use before they are distributed.

READ ALSO  Coronavirus: Governor Gives Conditions For Another Lockdown

Receiving the vaccines, the PSC Chairman and Secretary to the Government of the Federation (SGF), Boss Mustapha, appreciated the US government for the donation, noting that it came at a time when Nigeria had started recording about 500 COVID-19 cases daily.

He also mentioned that the PSC would publish the names of over 500 travelers who have violated the travel protocol and those who evaded quarantine.

Watch What's Trending!

 
0 0 votes
Article Rating
Subscribe
Notify of
guest

0 Comments
Inline Feedbacks
View all comments